|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
2
|
Resverlogix Corp.
|
Jun 27, 2017 11:23AM
|
|
Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 17, 2018 12:16PM
|
|
Re: News out...offering priced at $4
|
2
|
Resverlogix Corp.
|
May 15, 2019 08:38AM
|
|
Re: So what level will the PP be at?
|
2
|
Resverlogix Corp.
|
Mar 17, 2017 01:05PM
|
|
Re: I'm calling it a full on bear raid.....
|
2
|
Resverlogix Corp.
|
May 15, 2019 09:35AM
|
|
Investing in the fog
|
2
|
Resverlogix Corp.
|
Oct 28, 2016 12:02PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 17, 2018 05:33PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
2
|
Resverlogix Corp.
|
May 26, 2017 09:03PM
|
|
Big bid at $1.79 then $1.88 so I added a few
|
2
|
Resverlogix Corp.
|
Sep 28, 2016 03:35PM
|
|
Question on valuing shares from time of spinoff
|
2
|
Zenith Epigenetics
|
Jul 18, 2018 01:19PM
|
|
Re: Question on valuing shares from time of spinoff
|
2
|
Zenith Epigenetics
|
Jul 18, 2018 04:28PM
|
|
Re: Microcap bought in CVR deal - stock is up 700%
|
2
|
Resverlogix Corp.
|
Sep 20, 2016 04:17PM
|
|
Re: Roth research report
|
2
|
Resverlogix Corp.
|
Nov 01, 2018 03:44PM
|
|
ASCO study...Celgene
|
2
|
Zenith Epigenetics
|
Jun 01, 2019 10:48AM
|
|
Re: Getting excited again....Apebetalone - Digital Medicine...
|
2
|
Resverlogix Corp.
|
Aug 12, 2016 09:51AM
|
|
Evacetrapib fails
|
2
|
Resverlogix Corp.
|
May 18, 2017 07:07AM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
2
|
Resverlogix Corp.
|
Aug 11, 2018 03:09PM
|
|
Re: Wtf Debt?
|
2
|
Resverlogix Corp.
|
Jun 19, 2017 08:37PM
|
|
Re: Rvx-222 ... next molecule for testing ?
|
2
|
Resverlogix Corp.
|
Sep 29, 2015 12:37PM
|
|
Hmm...wonder if BMO analyst comes on board
|
2
|
Resverlogix Corp.
|
Jul 25, 2017 09:34AM
|
